Endometriosis Foundation Of Americainc is located in New York, NY. The organization was established in 2007. According to its NTEE Classification (T30) the organization is classified as: Public Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. As of 12/2022, Endometriosis Foundation Of Americainc employed 4 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Endometriosis Foundation Of Americainc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Endometriosis Foundation Of Americainc generated $1.3m in total revenue. This organization has experienced exceptional growth, as over the past 4 years, it has increased revenue by an average of 19.9% each year . All expenses for the organization totaled $1.1m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
THE ENDOMETRIOSIS FOUNDATION OF AMERICA (ENDOFOUND) STRIVES TO INCREASE DISEASE RECOGNITION, PROVIDE ADVOCACY, FACILITATE EXPERT SURGICAL TRAINING, AND FUND LANDMARK ENDOMETRIOSIS RESEARCH.
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE ENDOFOUND EDUCATION PROGRAM IS A SCHOOL AND COMMUNITY-BASED EDUCATION PROGRAM DESIGNED TO EDUCATE HIGH SCHOOL STUDENTS AND RAISE AWARENESS ABOUT ENDOMETRIOSIS THROUGH AN INTERACTIVE PROGRAM WHICH INCLUDES BOTH EDUCATION OF THE DISEASE AND TO TEACH STUDENTS HOW TO ADVOCATE FOR THEMSELVES. TO DATE, THE PROGRAM HAS EDUCATED 40,000 STUDENTS IN THE US AND ABROAD.
THE ENDOFOUND EDUCATION PROGRAM IS A SCHOOL AND COMMUNITY-BASED EDUCATION PROGRAM DESIGNED TO EDUCATE HIGH SCHOOL STUDENTS AND RAISE AWARENESS ABOUT ENDOMETRIOSIS THROUGH AN INTERACTIVE PROGRAM WHICH INCLUDES BOTH EDUCATION OF THE DISEASE AND TO TEACH STUDENTS HOW TO ADVOCATE FOR THEMSELVES. TO DATE, THE PROGRAM HAS EDUCATED 40,000 STUDENTS IN THE US AND ABROAD.
CONFERENCES AND WEBINARS: HISTORICALLY ENDOFOUND RUNS TWO LARGE ANNUAL CONFERENCES. THE FIRST IS A MEDICAL CONFERENCE WHICH GATHERS PHYSICIANS, SURGEONS, RESEARCHERS, NURSES, FROM ALL OVER THE WORLD TO LEARN ABOUT CURRENT TRENDS AND BEST PRACTICES FOR THE TREATMENT OF ENDOMETRIOSIS. THE SECOND IS A PATIENT CONFERENCE BRINGING PATIENTS AND PHYSICIANS TOGETHER TO LEARN IN DEPTH ABOUT ENDOMETRIOSIS, MANAGEMENT OF THE DISEASE, SUPPORT AVAILABLE AND WELLNESS TRAINING. BOTH CONFERENCES ARE HELD IN MARCH DURING ENDOMETRIOSIS AWARENESS MONTH. DUE TO COVID-19 RESTRICTIONS WHICH BEGAN DAYS BEFORE THE SCHEDULED CONFERENCES, ENDOFOUND SUCCESSFULLY PIVOTED TO ON-LINE WEBINARS AND CONFERENCES THROUGH THE END OF 2021 SO THAT IT COULD CONTINUE TO BRING BOTH PATIENTS AND MEDICAL PROFESSIONALS TOGETHER, AND DELIVER QUALITY INFORMATION THAT THE GROUPS HAVE COME TO RELY ON.
CONFERENCES AND WEBINARS: HISTORICALLY ENDOFOUND RUNS TWO LARGE ANNUAL CONFERENCES. THE FIRST IS A MEDICAL CONFERENCE WHICH GATHERS PHYSICIANS, SURGEONS, RESEARCHERS, NURSES, FROM ALL OVER THE WORLD TO LEARN ABOUT CURRENT TRENDS AND BEST PRACTICES FOR THE TREATMENT OF ENDOMETRIOSIS. THE SECOND IS A PATIENT CONFERENCE BRINGING PATIENTS AND PHYSICIANS TOGETHER TO LEARN IN DEPTH ABOUT ENDOMETRIOSIS, MANAGEMENT OF THE DISEASE, SUPPORT AVAILABLE AND WELLNESS TRAINING. BOTH CONFERENCES ARE HELD IN MARCH DURING ENDOMETRIOSIS AWARENESS MONTH. DUE TO COVID-19 RESTRICTIONS WHICH BEGAN DAYS BEFORE THE SCHEDULED CONFERENCES, ENDOFOUND SUCCESSFULLY PIVOTED TO ON-LINE WEBINARS AND CONFERENCES THROUGH THE END OF 2021 SO THAT IT COULD CONTINUE TO BRING BOTH PATIENTS AND MEDICAL PROFESSIONALS TOGETHER, AND DELIVER QUALITY INFORMATION THAT THE GROUPS HAVE COME TO RELY ON.
RESEARCH AND GRANTS - ENDOFOUND FUNDS CUTTING-EDGE MEDICAL RESEARCH AT MEDICAL INSTITUTIONS AND HOSPITALS IN THE US PREDOMINANTLY, AND IN OTHER COUNTRIES. RESEARCH IS CONDUCTED ON THE ETIOLOGY OF THE DISEASE, GENETIC IMPLICATIONS, AND ORGANS AFFECTED BY THE DISEASE, AMONG OTHERS, ALL WITH THE GOAL OF DEVELOPING BETTER DIAGNOSTICS AND BETTER TREATMENTS.
RESEARCH AND GRANTS - ENDOFOUND FUNDS CUTTING-EDGE MEDICAL RESEARCH AT MEDICAL INSTITUTIONS AND HOSPITALS IN THE US PREDOMINANTLY, AND IN OTHER COUNTRIES. RESEARCH IS CONDUCTED ON THE ETIOLOGY OF THE DISEASE, GENETIC IMPLICATIONS, AND ORGANS AFFECTED BY THE DISEASE, AMONG OTHERS, ALL WITH THE GOAL OF DEVELOPING BETTER DIAGNOSTICS AND BETTER TREATMENTS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Tamer Seckin MD President | OfficerTrustee | 5 | $0 |
Piraye Yurttas Beim PHD Director | OfficerTrustee | 2 | $0 |
Michael S Brodherson MD Director | Trustee | 2 | $0 |
Kristy Curry Director | Trustee | 2 | $0 |
Karli Goldstein DO Director | Trustee | 2 | $0 |
Tracey Haas DO MPH Director | OfficerTrustee | 2 | $25,000 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $162,500 |
Related organizations | $0 |
Government grants | $82,060 |
All other contributions, gifts, grants, and similar amounts not included above | $1,048,402 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $1,292,962 |
Total Program Service Revenue | $462,500 |
Investment income | $2,015 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $1,302,317 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $151,667 |
Compensation of current officers, directors, key employees. | $0 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $163,732 |
Pension plan accruals and contributions | $255 |
Other employee benefits | $37,487 |
Payroll taxes | $25,444 |
Fees for services: Management | $0 |
Fees for services: Legal | $20,091 |
Fees for services: Accounting | $33,982 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $323,288 |
Advertising and promotion | $35,091 |
Office expenses | $27,245 |
Information technology | $75,436 |
Royalties | $0 |
Occupancy | $0 |
Travel | $1,013 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $96,353 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,927 |
Insurance | $7,607 |
All other expenses | $0 |
Total functional expenses | $1,120,272 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $1,484,874 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $542,701 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $125,928 |
Net Land, buildings, and equipment | $3,114 |
Investments—publicly traded securities | $114,363 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $2,270,980 |
Accounts payable and accrued expenses | $146,710 |
Grants payable | $0 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $146,710 |
Net assets without donor restrictions | $1,299,270 |
Net assets with donor restrictions | $825,000 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $2,270,980 |
Over the last fiscal year, Endometriosis Foundation Of Americainc has awarded $50,000 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
NORTHWESTERN UNIVERSITY PURPOSE: Research | $25,000 |
YALE SCHOOL OF MEDICINE PURPOSE: Research | $25,000 |